Cochlear Limited (OC5.F)
- Previous Close
152.62 - Open
154.54 - Bid 153.48 x 20000
- Ask 155.02 x 20000
- Day's Range
154.54 - 154.54 - 52 Week Range
135.12 - 208.45 - Volume
55 - Avg. Volume
9 - Market Cap (intraday)
10.106B - Beta (5Y Monthly) 0.40
- PE Ratio (TTM)
47.70 - EPS (TTM)
3.24 - Earnings Date Aug 13, 2025 - Aug 18, 2025
- Forward Dividend & Yield 2.39 (1.57%)
- Ex-Dividend Date Mar 20, 2025
- 1y Target Est
--
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
www.cochlear.comRecent News: OC5.F
View MorePerformance Overview: OC5.F
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OC5.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OC5.F
View MoreValuation Measures
Market Cap
9.94B
Enterprise Value
9.86B
Trailing P/E
47.25
Forward P/E
38.46
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.58
Price/Book (mrq)
9.35
Enterprise Value/Revenue
7.47
Enterprise Value/EBITDA
28.87
Financial Highlights
Profitability and Income Statement
Profit Margin
16.05%
Return on Assets (ttm)
12.29%
Return on Equity (ttm)
20.31%
Revenue (ttm)
2.31B
Net Income Avi to Common (ttm)
370.5M
Diluted EPS (ttm)
3.24
Balance Sheet and Cash Flow
Total Cash (mrq)
383.1M
Total Debt/Equity (mrq)
13.20%
Levered Free Cash Flow (ttm)
254.24M